‹Return to Search Results

Drug Details

Drug Number:	454/08
Drug Name:	nelarabine (Atriance)
Drug Manufacturer:	GlaxoSmithKline UK
BNF Category:	Malignant disease and immunosuppression
Submission type :	Full submission
Date Advice Issued:	07 April 2008
Indication:	For the treatment of patients with T-cell acute lymphoblastic leukaemia (T-ALL) and T-cell lymphoblastic lymphoma (T-LBL)

Drug Advice

nelarabine (Atriance)

Press Statement

Read the press statement

Read the media briefing

Minutes

Read the minutes

Notes

‹Return to Search Results

Other SMC Advice for this Drug

There is currently no other SMC advice for this product

SEARCH FOR A DRUG

UNKNOWN - All BNF Categories - AnaesthesiaCardiovascular systemCentral nervous systemEar, nose and oropharynxEndocrine systemEyeGastro-intestinal systemImmunological products and vaccinesInfectionsMalignant disease and immunosuppressionMusculoskeletal and joint diseasesNutrition and bloodObstetrics, gynaecology, and urinary-tract disordersRespiratory systemSkin

UNKNOWN - All Types of Submission - Abbreviated SubmissionFull submissionIRPNon submissionResubmission

Help on how to improve your search.